2 results
Approved WMOCompleted
Part 1To evaluate the safety, tolerability, and pharmacokinetics (PK) of multiple intravenous doses of FEP-TAZ 4 g (2 g cefepime + 2 g tazobactam) and FEP-TAZ 3 g (2 g cefepime + 1 g tazobactam) administered every 8 hours (q8h) in healthy adult…
Approved WMORecruiting
The VOLT CE Mark study will collect data to demonstrate that the Volt PFA System is functioning as intended in a clinical setting and to demonstrate acute safety and effectiveness for the treatment of symptomatic, recurrent paroxysmal atrial…